Hyland’s launched Hyland’s Baby Nighttime teething tablets, a nighttime version to join its best-selling infant oral pain reliever Hyland’s Baby teething tablets in the $40 million infant oral pain segment.
Let’s face it: New products are the lifeblood of this business. If you’re a retailer, that’s why you went to NACDS Total Store Expo. That’s why DSN went to NACDS TSE, too. For two days, our reporters searched the show floor for the very latest and best new products and offerings at NACDS TSE.
Unilever revealed this month the new "Take Pride in Your Pregame" program featuring ESPN college football analyst and SEC Network host Jesse Palmer to help guys take pride in their everyday grooming routines.
Mylan announced that its subsidiary, Mylan Labs Limited, has signed an agreement with Gilead Science under which Mylan has been licensed the non-exclusive rights to manufacture and distribute sofosbuvir and the investigational single tablet regimen of ledipasvir/sofosbuvir in 91 developing countries.